Analystreport

Mesoblast limited (NASDAQ: MESO) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com